Dec. 2020 – The OMNI Institute served as the research partner and provided support with data collection, analysis, and reporting. OMNI is a non-profit research and evaluation consultancy with the mission of accelerating positive social change by supporting the public, nonprofit, and philanthropic sectors around the country with integrated research and evaluation, capacity building, and data utilization solutions. OMNI has more than four decades of experience conducting research and implementing best practices as they relate to substance use disorder treatment.
Soberlink and Aware Recovery Care’s study collected data related to patient demographics, substance use, medical outcomes, Soberlink testing data, and satisfaction with the Soberlink device. Patients (participants) were asked to complete a baseline survey and monthly follow-up surveys for six-months after enrollment. The study protocol and materials were reviewed and approved by an Institutional Review Board (IRB). Data collection began in April 2019 and was completed in June 2020. A total of 87 individuals participated in the study.
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…